BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8790953)

  • 1. Higher level of plasma cholesteryl ester transfer activity from high-density lipoprotein to apo B-containing lipoproteins in subjects with angiographically detectable coronary artery disease.
    Hibino T; Sakuma N; Sato T
    Clin Cardiol; 1996 Jun; 19(6):483-6. PubMed ID: 8790953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesteryl ester transfer activity. Localization and role in distribution of cholesteryl ester among lipoproteins in man.
    Groener JE; Van Rozen AJ; Erkelens DW
    Atherosclerosis; 1984 Mar; 50(3):261-71. PubMed ID: 6712775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma cholesteryl ester transfer protein concentration, high-density lipoprotein cholesterol esterification and transfer rates to lighter density lipoproteins in the fasting state and after a test meal are similar in Type II diabetics and normal controls.
    Lottenberg SA; Lottenberg AM; Nunes VS; McPherson R; Quintão EC
    Atherosclerosis; 1996 Nov; 127(1):81-90. PubMed ID: 9006808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma phospholipid mass transfer rate: relationship to plasma phospholipid and cholesteryl ester transfer activities and lipid parameters.
    Cheung MC; Wolfbauer G; Albers JJ
    Biochim Biophys Acta; 1996 Sep; 1303(2):103-10. PubMed ID: 8856039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein.
    Karpe F; Tornvall P; Olivecrona T; Steiner G; Carlson LA; Hamsten A
    Atherosclerosis; 1993 Jan; 98(1):33-49. PubMed ID: 8457249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia.
    Tall A; Sammett D; Granot E
    J Clin Invest; 1986 Apr; 77(4):1163-72. PubMed ID: 3958185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical markers of vasospastic coronary artery disease.
    Yamaguchi H; Homma Y; Handa S
    Nutr Metab Cardiovasc Dis; 2003 Dec; 13(6):365-71. PubMed ID: 14979683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of triglyceride concentration on the relationship between lipoprotein cholesterol and apolipoprotein B and A-I levels.
    Leroux G; Lemieux I; Lamarche B; Cantin B; Dagenais GR; Lupien PJ; Després JP
    Metabolism; 2000 Jan; 49(1):53-61. PubMed ID: 10647064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction.
    Tornvall P; Karpe F; Carlson LA; Hamsten A
    Atherosclerosis; 1991 Sep; 90(1):67-80. PubMed ID: 1799399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins.
    Pownall HJ; Brauchi D; Kilinç C; Osmundsen K; Pao Q; Payton-Ross C; Gotto AM; Ballantyne CM
    Atherosclerosis; 1999 Apr; 143(2):285-97. PubMed ID: 10217357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on cholesteryl ester transfer activity in coronary heart disease.
    Fujinuma Y; Tanaka A; Maezawa H
    Bull Tokyo Med Dent Univ; 1991 Sep; 38(3):27-33. PubMed ID: 1934199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice.
    Berti JA; Amaral ME; Boschero AC; Nunes VS; Harada LM; Castilho LN; Oliveira HC
    Metabolism; 2001 May; 50(5):530-6. PubMed ID: 11319713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin decreases plasma cholesteryl ester transfer but not cholesterol esterification in healthy subjects as well as in normotriglyceridaemic patients with type 2 diabetes.
    Dullaart RP; Riemens SC; Scheek LM; Van Tol A
    Eur J Clin Invest; 1999 Aug; 29(8):663-71. PubMed ID: 10457149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the intravascular metabolism of cholesteryl esters and apoproteins of plasma low- and high-density lipoproteins in the rat (Rattus norvegicus), an animal species without plasma cholesteryl ester transfer activity.
    Terpstra AH
    Comp Biochem Physiol B; 1993 Dec; 106(4):837-43. PubMed ID: 8299346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-density lipoprotein: relations to metabolic parameters and severity of coronary artery disease.
    Tornvall P; Karpe F; Proudler A; Båvenholm P; Landou C; Olivecrona T; Hamsten A
    Metabolism; 1996 Nov; 45(11):1375-82. PubMed ID: 8931642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of plasma levels and composition of apolipoprotein B-containing lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction.
    Tornvall P; Båvenholm P; Landou C; de Faire U; Hamsten A
    Circulation; 1993 Nov; 88(5 Pt 1):2180-9. PubMed ID: 8222113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides.
    Lahdenperä S; Syvänne M; Kahri J; Taskinen MR
    Diabetologia; 1996 Apr; 39(4):453-61. PubMed ID: 8777995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linkage of the cholesteryl ester transfer protein (CETP) gene to LDL particle size: use of a novel tetranucleotide repeat within the CETP promoter.
    Talmud PJ; Edwards KL; Turner CM; Newman B; Palmen JM; Humphries SE; Austin MA
    Circulation; 2000 May; 101(21):2461-6. PubMed ID: 10831518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
    Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
    Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin.
    Hodis HN; Mack WJ; Azen SP; Alaupovic P; Pogoda JM; LaBree L; Hemphill LC; Kramsch DM; Blankenhorn DH
    Circulation; 1994 Jul; 90(1):42-9. PubMed ID: 8026027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.